相关实验视频

Updated: Jun 16, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.6K

人类布鲁塞拉粘膜疫苗的开发:应该考虑什么?

Tingting Tian1, Yuejie Zhu2, Juan Shi1

  • 1State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, The First Affiliated hospital of Xinjiang Medical University, China.

Life sciences
|August 16, 2024
PubMed
概括

开发一种安全有效的粘膜疫苗对布鲁塞拉是非常重要的,因为它的动物性质和作为生物武器的潜力. 这篇评论探讨了粘膜免疫,布鲁塞拉感染,以及人类布鲁塞拉疫苗的策略.

关键词:
布鲁塞拉病毒是什么?粘膜辅助剂 粘膜辅助剂粘膜疫苗 粘膜疫苗 是一种目标化策略的目标化策略

更多相关视频

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells15:29

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Published on: August 5, 2016

8.2K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K

相关概念视频

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
296